COAG HEMAB THERAPEUTICS HOLDINGS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Tue 10 Nov 2026 · before market open
What 9 analyst firms say about HEMAB THERAPEUTICS HOLDINGS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 10 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8058
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8071
Recent analyst activity · last 90 days
Our tracked history has 5 reports on COAG from 5 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wedbush raised its target from $55.00 (set 13 Jul 2026) to $64.00 on 12 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Evercore ISI | Cory Kasimov | Buy | 26 May 2026 | Conflicting reports · excluded |
| Goldman Sachs | Richard Law | Buy | 26 May 2026 | Conflicting reports · excluded |
| H.C. Wainwright | Emily Bodnar | Buy | 11 Aug 2026 | 60.00 USD |
| Jefferies | Maury Raycroft | Buy | 13 Jul 2026 | 47.00 USD |
| JPMorgan | Joyce Zhou | Buy | 15 Oct 2026 | 70.00 USD |
| Rodman & Renshaw | Michael G King | Buy | 12 Oct 2026 | 56.00 USD |
| Rodman & Renshaw | Michael G. King Jr. | Buy | 12 Oct 2026 | 56.00 USD |
| Wedbush | David Nierengarten | Buy | 12 Aug 2026 | 64.00 USD |
| Weiss Ratings | Unnamed analyst | — | 25 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 27 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.